Please login to the form below

Not currently logged in
Email:
Password:

Mavenclad

This page shows the latest Mavenclad news and features for those working in and with pharma, biotech and healthcare.

Greater Manchester backs move to outcome-based payment

Greater Manchester backs move to outcome-based payment

Mavenclad, and a 'pay by cure' deal for hepatitis C treatments.

Latest news

More from news
Approximately 2 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • New models of NHS care – new models of pharma response? New models of NHS care – new models of pharma response?

    The Accelerated Access Collaborative. Ewan Barbour, Market Access and Pricing Director, Merck, presented on its multiple sclerosis treatment Mavenclad being selected to be among the first designated Rapid Uptake products on ... Ewan Barbour. He said the

  • Pharma: in search of the sustainable ‘win win’ with the NHS Pharma: in search of the sustainable ‘win win’ with the NHS

    The company has just secured 'Rapid Uptake' status for its multiple sclerosis drug Mavenclad via the new Accelerated Access Collaborative process.

  • Tackling a formidable foe Tackling a formidable foe

    MAVENCLAD offers lasting control of the disease allowing them to plan for pregnancy once the treatment course is completed. ... MAVENCLAD’S short-course oral therapy profile is a bonus to a condition freighted with psychological drag-weights.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics